Takeshi Motohara

CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth

Takatsugu Ishimoto, Osamu Nagano, Toshifumi Yae et al. · Cancer Cell · 2011 · 1.2K citations · Full text

Oncology, Redox Regulator, Medicine +11

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell

Toshifumi Yae, Kenji Tsuchihashi, Takatsugu Ishimoto et al. · Nature Communications · 2012 · 378 citations · Full text

Medicine, Cd44 Mrna, Cancer Cell Biology +9

xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma

Momoko Yoshikawa, Kenji Tsuchihashi, Takatsugu Ishimoto et al. · Cancer Research · 2013 · 189 citations

Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche

Fabrizio Miranda, David Mannion, Shujuan Liu et al. · Cancer Cell · 2016 · 171 citations · Full text

Salt-inducible Kinase 2, Adipocyte-rich Metastatic Niche, Medicine +12

The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer

Shingo Tayama, Takeshi Motohara, Dashdemberel Narantuya et al. · Oncotarget · 2017 · 100 citations · Full text

Epithelial Ovarian Cancer, Medicine, Cancer Management +15